RecruitingNCT05540288

Nalmefene or placebo for urges linked to gambling, eating, or sexual behaviors

About this title

Medication studyAges 18+FranceAddiction

The study in practice

Understand this study

Listed age limits: from 18 years.

Listed locations: Besançon and 12 more locationsSee all locations and recruitment
Study phase: Phase 3

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: March 31, 2023

Recruitment status: Recruiting
Enrollment listed in the registry: 266
Sponsor: Nantes University Hospital
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: France
Age range: Over 18 Years
Official registry ID: NCT05540288
Official title: Show the full official title
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions

Recruiting

Besançon · Bordeaux · Brest

10 more locations

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Nantes University Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Nalmefene and Placebo.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.